JP2004519431A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004519431A5 JP2004519431A5 JP2002545626A JP2002545626A JP2004519431A5 JP 2004519431 A5 JP2004519431 A5 JP 2004519431A5 JP 2002545626 A JP2002545626 A JP 2002545626A JP 2002545626 A JP2002545626 A JP 2002545626A JP 2004519431 A5 JP2004519431 A5 JP 2004519431A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- reovirus
- gene
- protein
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25013100P | 2000-12-01 | 2000-12-01 | |
| US32701601P | 2001-10-05 | 2001-10-05 | |
| PCT/CA2001/001703 WO2002043647A2 (en) | 2000-12-01 | 2001-11-30 | Oncolytic virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004519431A JP2004519431A (ja) | 2004-07-02 |
| JP2004519431A5 true JP2004519431A5 (https=) | 2005-12-22 |
Family
ID=26940619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002545626A Pending JP2004519431A (ja) | 2000-12-01 | 2001-11-30 | 腫瘍溶解性ウイルス |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1339736A2 (https=) |
| JP (1) | JP2004519431A (https=) |
| AU (2) | AU2002220416A1 (https=) |
| CA (1) | CA2430495A1 (https=) |
| WO (2) | WO2002043647A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ425699A0 (en) | 1999-11-25 | 1999-12-23 | University Of Newcastle Research Associates Limited, The | A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| AU2002953436A0 (en) | 2002-12-18 | 2003-01-09 | The University Of Newcastle Research Associates Limited | A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| WO2005111200A1 (en) * | 2004-05-17 | 2005-11-24 | Universite De Montreal | Novel strains of reoviruses and methods of uses thereof |
| WO2007099401A2 (en) | 2005-08-01 | 2007-09-07 | University Technologies International, Inc. | Oncolytic attenuated reoviruses for treatment of proliferative disorders |
| US10668119B2 (en) | 2005-08-01 | 2020-06-02 | Virocure, Inc. | Attenuated reovirus |
| JP5577103B2 (ja) | 2007-03-12 | 2014-08-20 | オンコリティクス バイオテク，インコーポレーテッド | 改変配列を有するレオウイルス |
| US10369171B2 (en) | 2007-03-13 | 2019-08-06 | Virocure, Inc. | Attenuated reoviruses for selection of cell populations |
| WO2019237063A1 (en) * | 2018-06-07 | 2019-12-12 | Emory University | Modified reoviruses, particles, and uses in treating proliferative disorders |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
| US6136307A (en) * | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
| CA2323067A1 (en) * | 1998-03-12 | 1999-09-16 | The Trustees Of The University Of Pennsylvania | Producer cells for replication selective viruses in the treatment of malignancy |
-
2001
- 2001-11-30 JP JP2002545626A patent/JP2004519431A/ja active Pending
- 2001-11-30 WO PCT/CA2001/001703 patent/WO2002043647A2/en not_active Ceased
- 2001-11-30 AU AU2002220416A patent/AU2002220416A1/en not_active Abandoned
- 2001-11-30 EP EP01998300A patent/EP1339736A2/en not_active Ceased
- 2001-11-30 CA CA002430495A patent/CA2430495A1/en not_active Abandoned
- 2001-12-03 WO PCT/US2001/045108 patent/WO2002050304A2/en not_active Ceased
- 2001-12-03 AU AU2002243257A patent/AU2002243257A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Marriott et al. | Defective interfering viruses and their potential as antiviral agents | |
| Barber | Vesicular stomatitis virus as an oncolytic vector | |
| ES2585553T3 (es) | Desarrollo de componentes de vacunas del virus del dengue | |
| Klasse | Molecular determinants of the ratio of inert to infectious virus particles | |
| JP6655618B2 (ja) | 安定な液体ワクシニアウイルス処方物 | |
| Ylösmäki et al. | Attenuation of Semliki Forest virus neurovirulence by microRNA-mediated detargeting | |
| JP2018520997A5 (https=) | ||
| WO2009039248A8 (en) | Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection | |
| MX2020003176A (es) | Variantes de capsides de virus adenoasociados y metodos de uso de estas. | |
| JP2007520214A5 (https=) | ||
| CN103547285A (zh) | 永生化的禽类细胞系及其用途 | |
| EA200801756A1 (ru) | Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса | |
| Lostroh | Molecular and cellular biology of viruses | |
| JP2013500720A5 (https=) | ||
| JP2016513115A5 (https=) | ||
| Le Nouën et al. | Attenuation of human respiratory viruses by synonymous genome recoding | |
| JP2019214579A5 (https=) | ||
| JP2004519431A5 (https=) | ||
| US20230158136A1 (en) | Viral nucleic acid molecules, and compositions and methods of use thereof | |
| ES2689150T3 (es) | Métodos para la prevención de agregación de componentes víricos | |
| Irie et al. | Sendai virus C proteins regulate viral genome and antigenome synthesis to dictate the negative genome polarity | |
| JP2009501001A5 (https=) | ||
| ES2606605T3 (es) | Vacuna para el BVDV | |
| WO2006136448A3 (en) | Attenuated sars and use as a vaccine | |
| WO2010107742A3 (en) | Methods and compositions of treating a flaviviridae family viral infection |